Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value consumer segments
LAS VEGAS, June 25, 2026 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT), the parent company of MyndSystem™, today announced that its nighttime repair formula, MyndRenew™, has received TruShield Certified status. This independent verification confirms that MyndRenew meets the rigorous anti-doping standards of the World Anti-Doping Agency (WADA) and the Ultimate Fighting Championship (UFC). Combined with the prior TruShield certification of MyndMed™ (the daytime performance formula), the full MyndSystem™ duo is now officially cleared for use by professional fighters and athletes subject to strict anti-doping protocols.
With this certification, MyndRenew™ joins MyndMed™ — which received TruShield™ clearance in August 2025 — to form the first complete, fully WADA-compliant 24/7 cognitive performance and repair system for professional athletes.
MyndSystem™ was originally developed for UFC fighters. The platform has since shown strong results across three key demographics that face similar challenges of accelerated brain stress and cognitive wear: professional fighters in their 20s, high-performing executives in their late 30s and 40s, and active seniors aged 55 and older. This broad applicability underscores the platform's science-backed approach to daytime cognitive performance (MyndMed™) and overnight brain repair and recovery (MyndRenew™).
"Securing TruShield certification for the complete MyndSystem is a major milestone," said Jamers Keener, CEO of BioAdaptives. "It not only validates the safety and quality of our formulations for the world's most scrutinized athletes but also significantly strengthens our position in the rapidly growing sports nutrition and performance supplement markets. With both products now WADA-compliant, we are well-positioned to pursue partnerships and adoption opportunities across professional leagues, including the UFC, and potentially other major sports organizations that prioritize clean, effective supplementation."
Strategic Implications for Shareholders
This certification enhances BioAdaptives' credibility and competitive differentiation within the premium performance nutrition category. Key potential benefits include:
For BioAdaptives shareholders, the certification marks an important commercial-readiness milestone. The Company believes that independent banned-substance certification may reduce a key barrier to adoption among professional and tested athletes, strengthen the credibility of the MyndSystem™ platform, and support future marketing initiatives for three primary audiences: